Production of human monoclonal antibodies specific for conformational and linear non-V3 epitopes of gp120
- PMID: 1380257
- DOI: 10.1089/aid.1992.8.1099
Production of human monoclonal antibodies specific for conformational and linear non-V3 epitopes of gp120
Abstract
Three IgG1 human monoclonal antibodies (MAbs) directed against conformational epitopes of the gp120 envelope protein of HIV-1 were produced, as was a single human MAb to a linear epitope spanning amino acids 487-509 in the C-terminal portion of gp120. All three conformation-dependent MAbs reacted optimally with recombinant gp120 (rgp120) captured on plastic via its carbohydrate moieties with Concanavalin A. These MAbs were able to block the interaction between recombinant CD4 (rCD4) and rgp120; they were also able to achieve 50% neutralization of HTLV-IIIB and MN strains of HIV-1 in a concentration range of 0.5-12.8 micrograms/mL. The MAb to the linear determinant is the first reported human MAb specific for the immunodominant portion of gp120; this MAb was most reactive with rgp120 when it was coated directly on plastic. It could neither inhibit rCD4-rgp120 binding nor neutralize either HTLV-IIIB or MN. The binding affinities of the four human MAbs for rgp120 in solution, reflected by their dissociation constants (Kd), ranged from 0.5 x 10(-8) to 7.5 x 10(-8) M.
Similar articles
-
Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans.J Virol. 1993 Feb;67(2):863-75. doi: 10.1128/JVI.67.2.863-875.1993. J Virol. 1993. PMID: 7678308 Free PMC article.
-
Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.Virology. 1997 Mar 17;229(2):360-9. doi: 10.1006/viro.1997.8443. Virology. 1997. PMID: 9126249
-
Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.J Virol. 2002 Sep;76(18):9035-45. doi: 10.1128/jvi.76.18.9035-9045.2002. J Virol. 2002. PMID: 12186887 Free PMC article.
-
HIV-1 neutralization directed to epitopes other than linear V3 determinants.AIDS. 1991;5 Suppl 2:S135-43. doi: 10.1097/00002030-199101001-00019. AIDS. 1991. PMID: 1726953 Review. No abstract available.
-
Antibodies against HIV-1 from phage display libraries: mapping of an immune response and progress towards antiviral immunotherapy.Chem Immunol. 1997;65:18-56. doi: 10.1159/000319346. Chem Immunol. 1997. PMID: 9018871 Review. No abstract available.
Cited by
-
Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans.J Virol. 1993 Feb;67(2):863-75. doi: 10.1128/JVI.67.2.863-875.1993. J Virol. 1993. PMID: 7678308 Free PMC article.
-
Resistance of a human serum-selected human immunodeficiency virus type 1 escape mutant to neutralization by CD4 binding site monoclonal antibodies is conferred by a single amino acid change in gp120.J Virol. 1993 Sep;67(9):5216-25. doi: 10.1128/JVI.67.9.5216-5225.1993. J Virol. 1993. PMID: 7688820 Free PMC article.
-
The use of immune complex vaccines to enhance antibody responses against neutralizing epitopes on HIV-1 envelope gp120.Vaccine. 2009 Dec 11;28(2):352-60. doi: 10.1016/j.vaccine.2009.10.040. Epub 2009 Oct 29. Vaccine. 2009. PMID: 19879224 Free PMC article.
-
Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.J Virol. 2000 Aug;74(15):7096-107. doi: 10.1128/jvi.74.15.7096-7107.2000. J Virol. 2000. PMID: 10888650 Free PMC article.
-
Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding.J Virol. 1995 Oct;69(10):6191-8. doi: 10.1128/JVI.69.10.6191-6198.1995. J Virol. 1995. PMID: 7545244 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials